Accepted at 8:59 p.m. Jan, 05, 2024 by Ahmed7
Author: barrwei99
Co-authors: Ahmed7
Related Note: 1474666075079
Rationale for change

September 2023: FDA no longer recommends phenylephrine as a nasal decongestant due to data showing lack of efficacy.
Source: Society Guidelines - https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-results-recent-advisory-committee-meeting-oral-phenylephrine

Extra Extra
Text
Pseudoephedrine and phenylephrine are {{c2::α-adrenergic}} {{c3::agonists}} that may be used as {{c1::nasal decongestants}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy





Watch Sympathomimetics
Sketchy 2


Watch Hypertension SOA
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Review Phenylephrine



Watch Phenylephrine and Pseudoephedrine
Physeo










Bootcamp
Watch associated Bootcamp video - Autonomic System : Direct Sympathomimetics
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::^Systems::Respiratory::Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::04_Sympathomimetics_&_Sympatholytics::08_Phenylephrine_and_Pseudoephedrine #AK_Step1_v12::#NBME::16 #AK_Step2_v12::#SketchyIM::01_Cardiology::06_Blood_Pressure::01_Hypertension_SOA #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#B&B::15_Neuro::04_Autonomic_Nervous_System::02_ANS_Drugs:_Norepinephrine #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::13_Sympatholytics_(alpha2-agonists)::*Sympatholytics_(a2-Agonists)::Pseudoephedrine #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::13_Sympatholytics_(alpha2-agonists)::*Sympatholytics_(a2-Agonists)::Phenylephrine #AK_Step1_v12::#AMBOSS #AK_Step1_v12::#AMBOSS::hlac9k #AK_Step1_v12::#Physeo::11_Pathology::01_Cardiac_Pathology::02_Hypertension #AK_Step1_v12::#FirstAid::16_Respiratory::05_Pharm::03_Pseudoephedrine_phenylephrine #PANCE::EENT::nose_and_sinus #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::04_Pseudoephedrine,_Phenylephrine #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#SketchyPharm::04_Smooth_Muscle::FA-pulm !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::11_Direct_Sympathomimetics #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Cardiology::Hypertension #AK_Step1_v12::#Pixorize::03_Pharmacology::23_Sympathomimetics_&_Sympatholytics_(New)::07_Phenylephrine #AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::02_Sympathetic::01_Sympathomimetics #AK_Step1_v12::#AMBOSS::gPaFVk #AK_Step1_v12::#B&B::05_Cardio::08_Hypertension::02_Secondary_Hypertension #AK_Original_Decks::Step_1::Zanki_Pharmacology